32 millones de personas viven con la enfermedad de Alzheimer. Luego de investigaciones decepcionantes se regresa al comienzo: los antivirales.
Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback